SARS-CoV-2 variant Omicron: currently the most complete "escapee" from neutralization by antibodies and vaccines
Signal Transduct Target Ther
.
2022 Jan 28;7(1):28.
doi: 10.1038/s41392-022-00880-9.
Authors
Maochen Li
#
1
,
Fuxing Lou
#
1
,
Huahao Fan
2
Affiliations
1
College of Life Science and Technology, Beijing University of Chemical Technology, 100029, Beijing, China.
2
College of Life Science and Technology, Beijing University of Chemical Technology, 100029, Beijing, China. fanhuahao@mail.buct.edu.cn.
#
Contributed equally.
PMID:
35091532
PMCID:
PMC8795721
DOI:
10.1038/s41392-022-00880-9
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Antibodies
COVID-19*
Humans
SARS-CoV-2
Vaccines*
Substances
Antibodies
Vaccines
Supplementary concepts
SARS-CoV-2 variants
Grants and funding
BUCTZY2022/Beijing University of Chemical Technology (BUCT)